Recurrence: all 3,523 studies
Page 25 of 36. Open to participants first (870), then studies with results posted, then the rest; newest registration first within each.
- A Trial of Cabazitaxel Chemotherapy in Relapsed Locally Advanced &/or Metastatic Carcinoma of the PenisCompletedNCT03114254Phase 2
- Pharmacokinetic Study of SPARC1613 and reference1613 in Subjects With Locally Recurrent or Metastatic Breast CancerCompletedNCT03109249Phase 1
- Blinatumomab in Adult Patients With Minimal Residual Disease (MRD) of B-precursor Acute Lymphoblastic LeukemiaCompletedNCT03109093Phase 2
- Intrathecal Pemetrexed for Recurrent Leptomeningeal Metastases From Non-small Cell Lung CancerCompletedNCT03101579Phase 1
- Oral Metronidazole With Lactobacillus Vaginal Suppositories to Prevent Recurrence of Bacterial VaginosisCompletedNCT03099408Phase 4
- Shuxuetong for Prevention of Recurrence in Acute Cerebrovascular Events With EmbolismCompletedNCT03090113Phase 4
- Single Agent Obinutuzumab in Relapsed/Refractory Post-Transplant Lymphoproliferative Disorder (PTLD)WithdrawnNCT03086395Phase 2
- A Trial of "Armored" CAR T Cells Targeting CD19 For Patients With Relapsed CD19+ Hematologic MalignanciesActive, not recruitingNCT03085173Phase 1
- High Dose Donor Hematopoietic Stem Cell Infusion for Relapsed/Refractory AMLStatus unknownNCT03080922Phase 1/2
- A Cognitive Behavioral Stress Intervention for Women Who SmokeCompletedNCT03077945Not applicable
- Study of Chiauranib in Relapsed/Refractory Non-Hodgkin's LymphomaTerminatedNCT03074825Phase 1
- New Therapeutic Strategies for Inhibitory Control in AlcoholismCompletedNCT03058276Not applicable
- Pyrimethamine for Intermediate/High-risk Myelodysplastic Syndromes (MDS)WithdrawnNCT03057990Phase 1
- Prevalence of Post-Thrombotic Syndrome in Deep-Vein Thrombosis (DVT) Patients Treated With DabigatranCompletedNCT03050138
- Off-therapy Response After Stopping Entecavir or TenofovirStatus unknownNCT03042481
- High Strength Cranberry Supplementation for Prevention of Recurrent Urinary Tract InfectionCompletedNCT03042273Phase 2
- Study Evaluating Safety and Efficacy of INCB050465 Combined With Bendamustine and Obinutuzumab in Relapsed or Refractory Follicular Lymphoma (CITADEL-102)CompletedNCT03039114Phase 1
- MCLA-117 in Acute Myelogenous LeukemiaTerminatedNCT03038230Phase 1
- Safety, PK, PD, and Antitumor Activity of Vecabrutinib (SNS-062) in B Lymphoid CancersTerminatedNCT03037645Phase 1/2
- Communication Strategies to Introduce Psychology ServicesCompletedNCT03035448Not applicable
- CD19 CAR T Cells in Patients With Relapsed or Refractory CD19 Positive B-cell LymphomaCompletedNCT03029338Phase 1
- NY-ESO-1 TCR （TAEST16001）for Patients With Advanced NSCLCStatus unknownNCT03029273Phase 1
- A Study of Fluzoparib Given in Combination With Apatinib and Paclitaxel in Gastric Cancer PatientsStatus unknownNCT03026881Phase 1
- Nivolumab Role in the Treatment of Patients With Refractory or Relapse Multiple MyelomaTerminatedNCT03023527Phase 1
- A Phase I Study Evaluating Safety and Efficacy of C-CAR011 Treatment in Adult Subjects With r/r CD19+B-ALLStatus unknownNCT03018093Phase 1
- Role of PRoactivE Coaching on PAtient REported Outcome in Advanced or Metastatic RCC Treated With Sunitinib or a Combination of Pembrolizumab + Axitinib or Avelumab + Axitinib in First Line TherapyTerminatedNCT03013946Phase 3
- Diet Intervention, Head and Neck Cancer, FeasibilityCompletedNCT03013699Not applicable
- Anti-tumor Necrosis Factor in Patients With Ulcerative Colitis in Clinical Remission: to Continue or Not?CompletedNCT03011268Not applicable
- Clinical Relevance of NGS Analysis for High-purity CTC From Cancer Patients With Disruptive Gene Mutation(s)Status unknownNCT03002350
- Evaluation of a Psychoeducation Program for Families Caregivers of Schizophrenic Patients : Randomized Study in Two ArmsStatus unknownNCT03000985Not applicable
- Evaluation of ProALL miRs in Blood Specimen for Prediction of ALL Relapse RiskStatus unknownNCT03000335
- Colon Cancer Treatment Decisions and Recurrence PredictingStatus unknownNCT02997241Not applicable
- Retrospective Analysis on Relapsed/Refractory Aggressive Non Hodgkin Lymphoma Treated With Z-BEAM Plus ASCTCompletedNCT02992223
- Clarithromycin,Lenalidomide and Dexamethasone for Relapsed/Refractory MyelomaWithdrawnNCT02986451Phase 2
- Paclitaxel,Cyclophosphamide and Dexamethasone for Relapsed or Refractory Multiple MyelomaWithdrawnNCT02985333Phase 2
- Therapy of Non-Hodgkin-Lymphoma by Combination of Lenalidomide + Rituximab, Dexa, High-dose ARA-C and CisPTerminatedNCT02983097Phase 1/2
- Study of Safety,Efficacy and Pharmacokinetics of CT-1530 in Patients With Relapsed or Refractory B Cell Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, and Waldenstrom's MacroglobulinemiaStatus unknownNCT02981745Phase 1/2
- A Dose Finding Study Followed by a Safety and Efficacy Study for Patients With Multiple Myeloma or LymphomaTerminatedNCT02978235Phase 1
- A Study Evaluating Venetoclax Alone and in Combination With Azacitidine in Participants With Relapsed/Refractory Myelodysplastic Syndromes (MDS)CompletedNCT02966782Phase 1
- Combination Radiation and PD-1 Inhibition in Metastatic or Recurrent Renal Cell Carcinoma (RCC)WithdrawnNCT02962804Phase 2
- Modified Measles Virus (MV-NIS) for Children and Young Adults With Recurrent Medulloblastoma or Recurrent ATRTCompletedNCT02962167Phase 1
- DAA in the Risk of Recurrence After Curative Treatment of HCCWithdrawnNCT02959359Phase 4
- A Study of the Tumor-targeting Human F16IL2 Monoclonal Antibody-cytokine Fusion Protein in Combination With Very Low-dose Cytarabine in Patients With AML Relapse After Allogeneic Hematopoietic Stem Cell TransplantationTerminatedNCT02957032Phase 1
- Testing JNJ-42756493 In Combination With Dexamethasone in Multiple Myeloma That Came Back After a Period of ImprovementTerminatedNCT02952573Phase 2
- Study of Iopofosine I-131 (CLR 131) in Select B-Cell Malignancies (CLOVER-1) With Expansion in WaldenstromActive, not recruitingNCT02952508Phase 2
- Anxiety and Reward Interaction and Prediction of Outcomes in Anorexia NervosaCompletedNCT02948452
- Mistletoe Therapy in Primary and Recurrent Inoperable Pancreatic CancerCompletedNCT02948309Phase 3
- Factors Influencing the 3-Year Recurrence of Liver Carcinoma After SurgeryCompletedNCT02941861
- Circulating Cell-free Tumor DNA(ctDNA) in Pancreatic CancerStatus unknownNCT02934984
- Wellness Monitoring for Major Depressive DisorderCompletedNCT02934334
- Safety and Dose Finding Study of Neratinib in Children and Young Adults With Cancer That Has Returned or Not Responded to TreatmentActive, not recruitingNCT02932280Phase 1/2
- Study of Laparoscopic Inguinal Hernia RepairCompletedNCT02920307Not applicable
- Interest of Fluorescence in Salvage Surgery for Recurrence of Head and Neck Cancer in Irradiated AreaCompletedNCT02920216Not applicable
- Study Evaluating the Efficacy and Safety With CAR-T for Relapsed or Refractory Neuroblastoma in ChildrenStatus unknownNCT02919046Not applicable
- Relapse of Ankylosing Spondylitis Patients Withdrawal Etanercept After Clinical Remission: a Following-up StudyCompletedNCT02915354Phase 4
- Low-Dose Daunorubicin in Relapsed/Refractory Acute LeukemiaCompletedNCT02914977Phase 1
- Study of Venetoclax in Combination With Carfilzomib and Dexamethasone in Participants With Relapsed or Refractory Multiple Myeloma (MM)Active, not recruitingNCT02899052Phase 2
- Modeling Cancer-specific Prognosis in Liver Transplantation for Hepatocellular Carcinoma (HCC)CompletedNCT02898415
- CAR19 Donor Lymphocytes for Relapsed CD19+ Malignancies Following Allogeneic TransplantationCompletedNCT02893189Phase 1
- The 10-years REPEATERS Cohort of French AdolescentsCompletedNCT02887170
- Chidamide Plus DCAG for Relapsed/Refractory AMLStatus unknownNCT02886559Phase 1/2
- MMRF Molecular Profiling ProtocolActive, not recruitingNCT02884102
- Chidamide Combined With Cyclophosphamide, Prednisone, Thalidomide in Treatment of Fragile Patients With Relapse/Refratory Peripheral T Cell LymphomaStatus unknownNCT02879526Phase 2
- Genomic/Epigenomic Biomarkers of Deregulation of Immune System in Inflammatory Bowel DiseasesStatus unknownNCT02878395
- Brain Functional Connectivity in Alcohol Use DisorderCompletedNCT02877849
- Study of Volasertib and Belinostat in Patients With Relapsed and Refractory Aggressive B-cell and T-cell LymphomasWithdrawnNCT02875002Phase 1
- Sorafenib Treatment in Patients With Hepatocellular Carcinoma With Microvascular Invasion After Radical ResectionTerminatedNCT02867280Phase 3
- Functional Connectivity Changes During Early Recovery as a Marker for RelapseCompletedNCT02861820
- Study on Surgical Treatment of Pilonidal Sinus DiseaseCompletedNCT02849197
- Understanding Communication in Healthcare to Achieve Trust (U-CHAT)CompletedNCT02846038
- BRAF/MEK Inhibition in Relapsed/Refractory Multiple Myeloma (BIRMA)CompletedNCT02834364Phase 2
- Phase I/II, FIH, Dose Escalation Trial of TL-895 and Expansion of TL-895 Monotherapy and Combination Therapy With Navtemadlin in Tx-Naïve and R/R CLL/SLL SubjectsActive, not recruitingNCT02825836Phase 1/2
- Lyon BJI Cohort StudyStatus unknownNCT02817711
- Robot-assisted Versus Laparoscopic Surgery for Mid/Low Rectal CancerStatus unknownNCT02817126Not applicable
- Chimeric Antigen Receptor T Cells (CART) Therapy in Refractory/Relapsed B Cell Hematologic MalignanciesStatus unknownNCT02813837Not applicable
- Study of Folfox4 Chemotherapy Regimen to Prevent Early Postoperative Recurrence for HCC-PVTT PatientsStatus unknownNCT02813096Not applicable
- Add-Aspirin: A Trial Assessing the Effects of Aspirin on Disease Recurrence and Survival After Primary Therapy in Common Non Metastatic Solid TumoursActive, not recruitingNCT02804815Phase 3
- Neural Indices Associated With Relapse in Cannabis DependenceStatus unknownNCT02801422
- Dose-Escalation Study of Pixantrone Monotherapy in Pediatric Patients With Relapsed or Refractory CancerWithdrawnNCT02800889Phase 1
- Allogeneic CART-19 for Elderly Relapsed/Refractory CD19+ ALLStatus unknownNCT02799550Phase 1
- Study on Reduced Antibiotic Treatment vs Broad Spectrum Betalactam in Patients With Bacteremia by EnterobacteriaceaeCompletedNCT02795949Phase 3
- CD22 Targeting CAR-T Therapy Against B Cell Hematological MalignanciesStatus unknownNCT02794961Phase 1/2
- The Clinical Relevance of P16 Expressing CTCs Detection Comparing With HPV Infection in Cancer Tissue in HNSCC Patients.Status unknownNCT02791607
- Nedaplatin Combined With Gemcitabine in the Treatment of Recurrent and/or Metastatic Nasopharyngeal Carcinoma : a Single Arm and Phase Ⅱ Clinical TrailTerminatedNCT02789189Phase 2
- Study of DPX-Survivac Therapy in Patients With Recurrent Ovarian CancerActive, not recruitingNCT02785250Phase 1/2
- Study of Busulfan and FLAG Conditioning Regimen for Allogeneic Peripheral Blood Stem Cell TransplantationStatus unknownNCT02784561Phase 4
- AZD2014 Plus Novel Anti-Cancer Agents in Relapsed or Refractory Diffuse Large B-Cell LymphomaWithdrawnNCT02780830Phase 1
- Alsertib (MLN8237) and Brentuximab Vedotin for Relapsed/Refractory CD30-Positive Lymphomas and Solid MalignanciesWithdrawnNCT02780011Phase 1
- Study of ACTR087 in Subjects With Relapsed or Refractory B-cell LymphomaCompletedNCT02776813Phase 1
- Rectal Bacteriotherapy, Fecal Microbiota Transplantation or Oral Vancomycin Treatment of Recurrent Clostridium Difficile InfectionsStatus unknownNCT02774382Phase 3
- A Study to Evaluate the Safety, Tolerability and Immunogenicity of EGFR(V)-EDV-Dox in Subjects With Recurrent GBMCompletedNCT02766699Phase 1
- Micro-embolic Signals Detection With Transcranial HOLter in Acute Ischemic STrokeCompletedNCT02762552Not applicable
- Study of Cytolytic Viral Activation Therapy (CVAT) for Recurrent/Metastatic Nasopharyngeal CarcinomaStatus unknownNCT02761291Phase 1
- Bevacizumab Alone Versus Dose-dense Temozolomide Followed by Bevacizumab for Recurrent Glioblastoma, Phase IIICompletedNCT02761070Phase 3
- The Swedish Study of Irrigation Fluid Temperature in the Evacuation of Chronic Subdural HematomaCompletedNCT02757235Not applicable
- Panobinostat in Combination With Carfilzomib and Dexamethasone in Relapsed or Relapsed and Refractory Multiple MyelomaWithdrawnNCT02756663Phase 2
- An Evaluation AZD2014 Alone and in Combination With Rituximab in Relapsed/Refractory Diffuse Large B Cell LymphomaCompletedNCT02752204Phase 2
- A Study of TB-403 in Pediatric Subjects With Relapsed or Refractory MedulloblastomaCompletedNCT02748135Phase 1
- Study of Ibrutinib in Combination With Bendamustine and Rituximab for Patients With Relapsed/Refractory Aggressive BCLStatus unknownNCT02747732Phase 2
- RCT for the Effectiveness of 3 Orthodontic Retention Schemes on Post-treatment Stability and Gingival RecessionStatus unknownNCT02742493Not applicable